TrialHealth technology assessment (Winchester, England)2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.
Fiona Collinson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.